Isolation of Multidrug-Resistant Bacteria as an Independent Mortality Factor in Patients with Suspected Sepsis at National Medical Center of the West
Main Article Content
Abstract
Introduction: In the changing epidemiological landscape sepsis corresponds to one of the main causes of in-hospital mortality, in third level care units the presence of multidrug resistant bacteria to antimicrobials correspond to a severe health problem, there are studies in intensive care units on mortality related to the appearance of multidrug resistant bacteria in cultures, however infection by multidrug resistant bacteria can appear at any instant of hospital stay which can become an independent risk factor for the appearance of mortality.
Aims: To associate the isolation of multidrug-resistant bacteria as an independent mortality factor in patients with suspected sepsis at the Centro Médico Nacional De Occidente.
Materials and methods: Place of study: Centro Médico Nacional De Occidente Guadalajara, Jalisco, Mexico. Type of study: Clinical, retrospective cohort type. The clinical records of patients admitted during the study period were searched. Patients with suspected sepsis according to the definition of the Third International Consensus were identified from continuous medical admission and followed up throughout their stay in the hospital. Patients with culture results were evaluated. Two follow-up cohorts were identified: those who presented isolation of multidrug-resistant bacteria at any time during hospitalization and the second cohort those who did not present isolation of multidrug-resistant bacteria; an initial determination of the variables was made and then the clinical records of the patients during their stay in the services were reviewed to search for in-hospital mortality. The association between the occurrence of multidrug-resistant bacteria and mortality was estimated by Hazard Ratio (with 95% confidence intervals).
Results: A total of 94 patients were included with a minimum age of 16 years and a maximum age of 91 years with a mean of 48 years with a standard deviation of 20 years. A total of 93 cultures were included of which 21 (22.3%) were isolated with bacterial resistance. Of the positive cultures 42 % (9) were blood culture, 10 % (2) were surgical wound cultures, urine culture 23 % (5), bronchial aspirate 23 % (5). Regarding mortality, 57 % of the patients who presented bacterial resistance presented mortality, presenting a Hazard Ratio of 3.371 with 95% CI (1.125-10.100) p=0.02 Table 2 and 3. Regarding mortality with the different types of bacteria, it was 40 % in Gram negative bacteria with a Hazard Ratio of 1.875 (0.291-12.089), while it was 20 % in Gram positive bacteria, which was not statistically significant p=0.3.
Conclusion: Isolation of multidrug-resistant bacteria is an independent mortality factor in patients with suspected sepsis at Centro Médico Nacional De Occidente. There is no relationship with the isolation of Gram-positive and Gram-negative bacteria type with respect to patient mortality.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Critical Care Medicine. 2017;351:524.
II. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc. 2016;334:1178–1184.
III. Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens YE, Avondo A, et al. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA - J Am Med Assoc. 2017;337:785–786.
IV. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. The Lancet. 2018;62:1025–1040.
V. Howell MD, Davis AM. Management of sepsis and septic shock. JAMA - Journal of the American Medical Association. 2017;49:873–883.
VI. Boechat AL, Boechat NO. Sepse: Diagnóstico e Tratamento. Rev Bras Clin Med. 2010;35(Suppl 106):6–7.
VII. Units C, Brazil S. Sepse Brasil : Estudo Epidemiológico da Sepse em Unidades de terapia intensiva Brasileiras * An Epidemiological Study of Sepsis in Intensive. Rev Bras Ter Intensiva. 2006;134:298–314.
VIII. Taniguchi LU, Bierrenbach AL, Toscano CM, Schettino GP, Azevedo LC. Sepsis-related deaths in Brazil: an analysis of the national mortality registry from 2002 to 2010. Crit Care. 2014;33:283–289.
IX. Carrillo-Esper R, Carrillo-Córdova JR, Daniel Carrillo-Córdova L. Estudio epidemiológico de la sepsis en unidades de terapia intensiva mexicanas, Cir Ciruj. 2009;103:1103–1113.
X. Centers for Disease Control and Prevention. National Hospital Discharge Survey. Natl Hosp Disch Surv. 2010; 51:386–389.
XI. Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report. 2010; 144:191–197.
XII. Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JÁ, Gordo F, et al. Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward*. Crit Care Med [Internet]. 2007;17:1078–1079.
XIII. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in Older Americans. J Am Geriatr Soc. 2012; 339:520–532.
XIV. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med. 2007; 40:562–573.
XV. Barnato AE, Alexander SL, Linde-Zwirble WT, Angus DC. Racial variation in the incidence, care, and outcomes of severe sepsis: Analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med. 2008; 114:1693–1696.
XVI. Cheng AC, West TE, Limmathurotsakul D, Peacock SJ. Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med. 2008; 344:1294–1303.
XVII. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;338:1641–1649.
XVIII. Gebremedhin D, Berhe H, Gebrekirstos K. Risk factors for neonatal sepsis in public hospitals of Mekelle City, North Ethiopia, 2015: Unmatched case control study. PLoS One. 2016;63:353–365.
XIX. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the united states. Crit Care Med. 2013;345:1147–1154.
XX. Ho HSS, Yip SKH, Lim KB, Fook S, Foo KT, Cheng CWS. A Prospective Randomized Study Comparing Monopolar and Bipolar Transurethral Resection of Prostate Using Transurethral Resection in Saline (TURIS) System. Eur Urol. 2007;340:1525–1532.
XXI. Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: Time for change. The Lancet. 2013;340:1581–1582.
XXII. Fisher JF, Meroueh SO, Mobashery S. Bacterial resistance to β-lactam antibiotics: Compelling opportunism, compelling opportunity. Chemical Reviews. 2005;342:1242–1249.
XXIII. Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE. The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2015; 21:1378–1385.
XXIV. Cohen J. Sepsis. Medicine. 2009;47: 475–477.
XXV. Majuran M, Clancy M. Determination of the size of the different sepsis categories presenting to a UK teaching hospital emergency department. Emerg Med J. 2008; 340:493–501.
XXVI. Beutz MA, Abraham E. Community-acquired pneumonia and sepsis. Clinics in Chest Medicine. 2005;346:1200–1206.
XXVII. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)*****. Jama. 2016;346:1243–1244
XXVIII. Ramachandran G. Gram-positive and gram-negative bacterial toxins in sepsis: A brief review. Virulence. 2014;338:1861–1868
XXIX. Preiser JC, Vincent JL. Sepsis. En: Metabolism of Human Diseases: Organ Physiology and Pathophysiology. 2014;343:1917–1924
XXX. Santos N de Q. Bacterial resistence in the context of hospital infection. Texto Context Enferm. 2004;40:1288–1297.
XXXI. Lam SJ, O’Brien-Simpson NM, Pantarat N, Sulistio A, Wong EHH, Chen YY, et al. Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers. Nat Microbiol. 2016; 96:11–16.
XXXII. Strich JR, Palmore TN. Preventing Transmission of Multidrug-Resistant Pathogens in the Intensive Care Unit. Infect Dis Clin North Am [Internet]. septiembre de 2017 [citado el 27 de noviembre de 2018];31(3):535–50. Recuperado a partir de: http://www.ncbi.nlm.nih.gov/pubmed/28687211
XXXIII. Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;40:1298–1300.
XXXIV. Derde LPG, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJL, Gniadkowski M, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis [Internet]. enero de 2014 [citado el 27 de noviembre de 2018];14(1):31–9. Recuperado a partir de: http://www.ncbi.nlm.nih.gov/pubmed/24161233
XXXV. Fraimow HS, Tsigrelis C. Antimicrobial Resistance in the Intensive Care Unit: Mechanisms, Epidemiology, and Management of Specific Resistant Pathogens. Critical Care Clinics. 2011;2:494–498.
XXXVI. Benavides-Plascencia L, Aldama-Ojeda AL, Vázquez HJ. Vigilancia de los niveles de uso de antibioticos y perfiles de resistencia bacteriana en hospitales de tercer nivel de la Ciudad de México. Salud Publica Mex. 2005;3:496–501
XXXVII. Munro N. Antimicrobial resistance. AACN Adv Crit Care. 2015;33:757–762.
XXXVIII. Macvane SH. Antimicrobial Resistance in the Intensive Care Unit. J Intensive Care Med. 2017; 38:1279–1286.
XXXIX. Haverkate MR, Derde LPG, Brun-Buisson C, Bonten MJM, Bootsma MCJ. Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Med. 2014; 6:427–430.